If have a business interest in Human Microbiome, or looking to network with senior executives and influencers within the space, learn more about the Microbiome Congress Conference, taking place in London, UK this November 18-19, 2015.
Here’s a quick look at the Microbiome Congress Conference Day Two Agenda:
For the full speaker list with session details, download the full brochure now.
Time of Session |
Type of Session |
Title of Session |
Session Speakers |
8:30 |
Registration |
||
9:00 |
Chairperson's Opening Remarks |
||
9:10 |
Faecalibacterium Prausnitzii and Inflammatory Bowel Disease |
Harry Sokol, Gastroenterology Department, Saint-Antoine Hospital, Paris, France |
|
9:35 |
Track A | Beta Lactamases, from Enemies to Therapies: Basis for the Development of SYN-004 | Michael Kaleko, MD, PhD, Senior Vice President, Research & Development, Synthietic Biologics |
9:35 |
Track B | Regulating the Microbiome: Lessons from OpenBiome, an international public stool-bank | Carolyn Edelstein, Director of Policy and Global Partnerships, OpenBiome |
10:00 |
Track A | Oral Microbiome and General Health |
Egija Zaura, Associate Professor - Oral Microbial Ecology, Department of Preventative Dentistry, Academic Centre of Dentistry Amsterdam (ACTA) |
10:00 |
Track B | Fecal Microbiota Transplantation: From current practices to future therapies | Mark Smith, Research Director, OpenBiome |
10:25 |
Track A | Microbiota Composition in IBS and Functional Gastrointestinal Diseases |
Sasha Zhernakova, Assistant Professor, University of Groningen Rosalind Franklin Fellowship, University of Groningen |
10:25 |
Track B | Landscape of gut microbiome in a Dutch population | Jingyuan Fu, Associate Professor, Department of Pediatrics & Department of Genetics, University Medical Center Groningen |
10:50 |
Morning Networking Break |
||
11:20 |
Case Study |
Towards an Affordable Diagnosis Based on Human Microbiome - Colorectal Cancer as a Case Study |
Dr. Manimozhiyan Arumugam, Group Leader and Associate Professor, Novo Nordisk Foundation Centre for Metabolic Research, University of Copenhagen |
11:45 |
Intestinal Microbiota in Metabolic Syndrome and Type 2 Diabetes: Cause or Consequence? |
Max Niewdorp, Professor in Internal Medicine and Diabetes, AMC Amsterdam & Visiting Professor, Gothenborg University |
|
12:10 |
Towards Population-level Microbiome Monitoring: The Flemish Gut Flora Project |
Jeroen Raes, Professor - Department of Microbiology and Immunology VIB Lab for Bioinformatics and (Eco) Systems Biology, KULeuven |
|
12:35 |
Networking Lunch |
||
14:00 |
Track A | Skin Microbiome in Health and Disease |
Frank Nestle, Professor & NIHR Senior Investigator, St John's Institute of Dermatology, King's College London and Guy's & St Thomas' Hospitals |
14:00 |
Track B | Vaginal Microbiome Dysbiosis: Relevance and Treatment |
Janneke van de Wijgert, Clinical Epidemiologist & Professor, Insitute of Infection and Global Health, University of Liverpool |
14:35 |
Track A | Infant Gut Microbiota and Dietary Interventions |
Bernard Berger, Senior Scientist, Nestlé Research Centre in Nutrition and Health Research |
14:35 |
Track B | Modelling the Emergent Dynamics and Major Metabolites of the Human Colonic Microbiota | Helen Kettle, Mathematical Modeller, Biomathematics and Statistics Scotland, Edinbrough |
14:55 |
Microbiome research ethics and legal landscape Sequencing microbial material from humans means sequencing the human genome – ethical and regulatory considerations? | Pilar N. Ossorio, Professor of Law and Bioethics, Ethics Scholar -in–Residence, Morgridge Inst. for Research, University of Wisconsin Law School | |
15:20 |
Track A | Towards the 3rd Wave of Probiotic and Therapeutic Microbes |
Johan E.T. van Hylckama Vlieg, Senior Director Microbiome - Health & Nutrition Division, Chr. Hansen |
15:20 |
Track B | Probiotics: from myth to molecular modes of action | Patrick Veiga, Senior Scientist - Danone Nutricia Research, Life Science Department; Visiting Scientist - Harvard School of Public Health, Dept. of Immunology and Infectious Diseases, Danone Nutricia Research |
15:45 |
Colorectal Cancer and the Gut Microbiome - Translational Applications of Gut Microbiome Research | James Kinross, Senior Lecturer in Colorectal Surgery, Imperial College London | |
16:05 |
The Microbiome-Gut-Brain Axis in Autism |
Ruth Ann Luna, Director, Medical Metagenomics, Texas Children’s Microbiome Center, Texas Children’s Hospital & Assistant Professor, Baylor College of Medicine |
|
16:30 |
Patient engagement in Microbiome Research |
Moderator: Ailsa Hart, Director IBD Unit and Sub-Dean, St Mark’s Hospital and Senior Clinical Lecturer, Department of Surgery and Cancer, Imperial College, London Fiona Copeland, Chair - PCD Family Support Group Alastair Kent OBE, Director of Genetic Alliance UK Deborah Trenchard, Patient |
|
17:10 |
Close of Conference |
For the full speaker list with session details, download the full brochure now.